Used primarily as a prodrug in the treatment of bacterial infections, this compound is effective against a broad range of Gram-positive and Gram-negative bacteria. It is commonly prescribed for respiratory tract infections, urinary tract infections, and skin and soft tissue infections. After oral administration, it is hydrolyzed to the active form, cefotiam, which inhibits bacterial cell wall synthesis. Its hexetil ester modification enhances oral absorption, making it suitable for outpatient therapy where intravenous delivery is not feasible. Frequently used in mild to moderate infections, it offers a convenient oral alternative to parenteral cephalosporins.